Kaijing Yan, Chairman of Tasly Holding Group, and Wei Wang, Founder of XINGYUN Group, joined forces with Professor Wei Jia and Dr. Ya Cai to explore the future of the ready-to-drink (RTD) tea industry.

Against the broader policy backdrop of the National Health Commission’s launch of the “Year of Weight Management” and the “Three Reductions, Three Health Improvements” initiative, a surge in health-conscious consumer demand is converging with the global rise of tea culture. In this context, two industry titans have integrated their strengths—bridging pharmaceutical innovation with a globalized supply chain—to introduce a pioneering product that marks a new chapter in RTD tea.

Does this collaboration signal China’s entry into the RTD Tea 3.0 era? Is the industry on the cusp of a transformation, with functional tea evolving from category innovation to a model of precise health management?

China's RTD tea market is poised to embark on a new chapter of health-driven evolution and multidimensional value enhancement.